Drug application
SANCUSO (GRANISETRON)
Drugs@FDA NDA 022198 · APOTEX
Key facts
| Drug name | SANCUSO |
|---|---|
| Active ingredients | GRANISETRON |
| Application type | NDA |
| Application number | 022198 |
| Company | APOTEX |
| Dosage forms | FILM, EXTENDED RELEASE, TRANSDERMAL |
| Strength | 3.1MG/24HR |
| Marketing status | Prescription |
| Reference listed drug | Yes |
| Latest submission class | Type 2 - New Active Ingredient |
| Latest submission status date | Sep 12, 2008 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: